AstraZeneca: News
28 May 2025
CancerSoon, cancer-fighting cells could be engineered inside our bodies
In the 1990s, when Bruce Levine and his colleagues first explored engineering immune cells to fight cancer, the scientific community was skeptical.
11 Apr 2025
England'Game-changing' pill that slows breast cancer approved
In a major healthcare development, the National Health Service (NHS) in England and Wales will now offer a twice-a-day pill, capivasertib, to women with advanced breast cancer.
03 Mar 2025
CancerAstraZeneca can now sell its cancer drug in India
AstraZeneca Pharma India Ltd has received the nod from the Central Drugs Standard Control Organisation (CDSCO) to import and sell a cancer treatment drug called Durvalumab.
28 Nov 2024
DiabetesNew drug offers breakthrough in Asthma, COPD treatment in 50-years
A new clinical trial has unveiled a promising way to treat severe asthma and chronic obstructive pulmonary disease (COPD) attacks.
16 Sep 2024
Health & WellnessThis drug shows promise in extending bladder cancer patients' lives
AstraZeneca's Imfinzi drug has shown significant potential in prolonging lives of patients with bladder cancer.
20 May 2024
Indian Council of Medical Research (ICMR)'Poor methodology': ICMR dissociates itself from Covaxin safety study
The Indian Council of Medical Research has disassociated itself from a Covaxin vaccine study conducted by the Banaras Hindu University (BHU).
17 May 2024
COVAXINAfter Covishield, new study finds side effects in Covaxin recipients
A recent study published in Springer Nature revealed that over 30% of Covaxin recipients reported "adverse events of special interest" (AESI).
16 May 2024
AustraliaAstraZeneca COVID vaccine linked to another rare blood clotting disorder
A new research has linked AstraZeneca's COVID-19 vaccine to an increased risk of a rare but fatal blood clotting disorder known as Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).
08 May 2024
COVID-19AstraZeneca says it will withdraw Covid-19 vaccine globally
The United Kingdom-based pharmaceutical company, AstraZeneca, on Tuesday said that it has initiated a worldwide recall of Covid-19 vaccine.
02 May 2024
COVID-19Should I be worried if I have taken AstraZeneca's Covishield?
AstraZeneca, the pharmaceutical company behind the Covishield COVID-19 vaccine, recently acknowledged the potential risk of Thrombosis with Thrombocytopenia Syndrome (TTS) as a side effect.
01 May 2024
CovishieldAstrazeneca upholds vaccine safety amid health concerns
AstraZeneca has reaffirmed its dedication to patient safety amid reports of rare side effects from the AstraZeneca-Oxford COVID-19 vaccine.
30 Apr 2024
COVID-19Explained: What's TTS, rare condition caused by AstraZeneca's Covishield vaccine
In a significant development, AstraZeneca, the manufacturer of the Covishield vaccine, has acknowledged in legal documents that its vaccine may trigger a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS).
17 Dec 2021
United States of AmericaAstraZeneca's antibody cocktail Evusheld effective against Omicron, finds study
AstraZeneca COVID-19 antibody cocktail, Evusheld, effectively works against the Omicron variant of coronavirus, the company said Thursday citing a lab study.
03 Dec 2021
PfizerCOVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
Seven COVID-19 vaccines are safe and stimulate a strong immune response when used as a booster jab to those who have already vaccinated, a study published in The Lancet said.
03 Sep 2021
North KoreaKim orders tougher virus steps after North Korea shuns vaccines
North Korean leader Kim Jong Un ordered officials to wage a tougher epidemic prevention campaign after he turned down some foreign COVID-19 vaccines offered via the UN-backed immunization program.
05 Aug 2021
Oxford UniversityCOVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll
Mattel, the maker of the Barbie doll, has created a doll to honor Professor Sarah Gilbert, who led the development of the Oxford University and AstraZeneca COVID-19 vaccine.
04 Aug 2021
COVID-19India mulls mixing Covishield, Sputnik doses; no recommendation yet
India is considering allowing the mixing of different COVID-19 vaccine doses in what could be the first mix-and-match inoculation.
17 Jul 2021
FranceFrance allows visitors vaccinated with Indian-made AstraZeneca vaccine
France will now allow international travelers who have received AstraZeneca's Indian-manufactured vaccine into the country starting Sunday.
02 Jul 2021
IndiaMix-and-match COVID-19 vaccines: What do studies say?
In most coronavirus vaccination regimes, two doses of the same brand are given a few weeks apart.
24 Jun 2021
PfizerSingle dose of Pfizer, AstraZeneca vaccines offers 60 percent protection
A single dose of Pfizer or AstraZeneca COVID-19 vaccine offers around 60 percent protection against infection from SARS-CoV-2 in adults aged 65 years and above, according to a study published in The Lancet Infectious Diseases.
19 Jun 2021
World Health OrganizationEfforts on to restart AstraZeneca shipments from India: WHO official
The WHO is urgently trying to work with AstraZeneca, Serum Institute of India (SII) as well as the Indian government to restart shipments of COVID-19 vaccines to countries, a senior official at the UN health agency said.
15 Jun 2021
PfizerPfizer, AstraZeneca vaccines protect against Delta variant, says study
Pfizer and AstraZeneca vaccines provide good protection against the Delta variant of coronavirus, first identified in India, says a study published in The Lancet Journal.
10 Jun 2021
COVID-19 VaccineAstraZeneca vaccine linked to small risk of low blood platelets
The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a small risk of developing a blood condition characterized by low platelet counts, according to a UK study.
21 May 2021
EnglandTwo doses of AstraZeneca vaccine 85%-90% effective, real-world data shows
Two doses of the Oxford/AstraZeneca COVID-19 vaccine are around 85 percent to 90 percent effective against the symptomatic disease, Public Health England (PHE) has said, citing a new analysis of real-world data from the roll-out of the shot in the UK.
11 May 2021
PfizerAstraZeneca vaccine's single dose reduces death risk by 80%: Data
A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said on Monday, citing data from the vaccine's rollout.
02 May 2021
VaccineCOVID-19 vaccine formulas shouldn't be shared with India: Bill Gates
It's a terrible time to be a publicist for Bill Gates. The billionaire, who the mainstream media celebrates as a philanthropist, is being criticized for his stance on vaccine patents.
15 Apr 2021
DenmarkDenmark becomes first European country to permanently drop AstraZeneca vaccine
Even as vaccines became the world's biggest hope against the highly contagious coronavirus, Denmark has stopped using the one made by British-Swedish pharma giant AstraZeneca.
08 Apr 2021
Serum Institute of IndiaAstraZeneca serves legal notice to Serum Institute over vaccine delays
Serum Institute of India (SII), the manufacturer of the coronavirus vaccine Covishield, has been served a legal notice by the drug maker AstraZeneca over delays in vaccine supply, the company's CEO Adar Poonawalla confirmed in an interview earlier this week.
03 Apr 2021
COVID-19 VaccinationUK: Seven blood-clotting-related deaths in 18mn AstraZeneca COVID-19 vaccine recipients
On Saturday, the United Kingdom's medical regulator said that seven people—out of more than 18 million recipients of the Oxford-AstraZeneca jab for COVID-19 in the country—died of unusual blood clots.
02 Apr 2021
Sri LankaFacing delay in securing vaccines, Lanka temporarily suspends COVID-19 jabs
Sri Lanka has temporarily halted its COVID-19 vaccination program as there was a delay in securing more AstraZeneca vaccines from the Serum Institute of India (SII), a top health minister has said.
31 Mar 2021
GermanyGermany halts AstraZeneca vaccine use for under-60s over clot fears
Germany will allow general use of the AstraZeneca coronavirus vaccine only for people aged above 60 years, imposing restrictions on younger people taking the jab after several severe cases of blood clots were reported, the German government said on Tuesday.
25 Mar 2021
VaccineAmid growing cases, India temporarily halts export of AstraZeneca's vaccine
Facing a sudden spike in coronavirus cases, India has halted the export of the AstraZeneca vaccine for now, Reuters reported quoting two sources. Millions of doses of the vaccine are being manufactured by the Pune-based Serum Institute of India (SII), the world's biggest vaccine-maker.
22 Mar 2021
CoronavirusAstraZeneca says US trial data shows vaccine 79% effective
AstraZeneca says advanced trial data from a US study on its COVID-19 vaccine shows it is 79 percent effective.
19 Mar 2021
EuropeAstraZeneca's coronavirus vaccine dubbed safe; European countries to resume vaccination
A chunk of European countries, that had earlier stopped using AstraZeneca's coronavirus vaccine over blood clot concerns, will resume the vaccination drive after the jab got the support of the continent's top medical regulator.
16 Mar 2021
ItalyWhy European countries are halting the AstraZeneca shot
The largest and most influential European countries, like Germany, France, and Italy, have paused the rollout of coronavirus vaccine, developed by the University of Oxford and British-Swedish pharma giant AstraZeneca over blood clot fears.
13 Mar 2021
IndiaLooking at adverse effects: India on concerns over AstraZeneca vaccine
India is constantly looking at all the adverse side effects as it conducts a massive coronavirus vaccination program, a top medical expert said today.
12 Mar 2021
DenmarkUse of AstraZeneca's coronavirus vaccine suspended in Denmark, Norway, Iceland
Denmark, Norway, and Iceland have temporarily suspended the use of the coronavirus vaccine developed by British-Swedish pharma giant AstraZeneca as several patients developed blood clots after getting the jab.
01 Mar 2021
CoronavirusAstraZeneca has sold its stake in Moderna for $1 billion
British pharmaceutical company AstraZeneca Plc has sold its 7.7 percent stake in Moderna Inc., the American pharmaceutical giant, for more than $1 billion, according to a report in The Times.
25 Feb 2021
Serum Institute of IndiaCOVID-19 vaccines: SII to play huge role in mass production
British-Swedish pharmaceutical giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
16 Feb 2021
World Health OrganizationWHO authorizes AstraZeneca's COVID-19 vaccine for emergency use
The World Health Organization has granted an emergency authorization to AstraZeneca's coronavirus vaccine, a move that should allow the UN agency's partners to ship millions of doses to countries as part of a UN-backed program to tame the pandemic.
